CSI Market
Sign In | Register

Bodisen Biotech Inc (BBCZ) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access BBCZ Annual Cash Flow →
Looking at cash flow data from Bodisen Biotech Inc through Dec 31 2011 provides insight into Jun 30 2013's financial flexibility across reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2013)
6 Months 		(Sep 30 2012) (Jun 30 2012) (Mar 31 2012) (Dec 31 2011)
Operating Activities
Income-1.85
Depreciation & amortization0.56
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue-0.12
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.66
Increase (Decrease) in Inventories0.70
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.41
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Increase Decrease Advances To Suppliers0.00
Increase Decrease In Other Payable0.02
Income taxes0.00
Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net0.00
Accounts Receivable0.32
Increase (Decrease) in Accounts Payable-0.17
Increase (Decrease) in Accrued Liabilities-0.03
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense-0.01
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities0.47
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.82
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Proceedsfromrepaymentofnotereceivable-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Proceeds from Sale of Notes Receivable0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.82
Financing Activities
Short-term debt Net-1.44
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-1.44
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow1.29
Total Cash Flow-0.15
4 historic quarters locked

Sign in to unlock the full Bodisen Biotech Inc cash flow history.

Sign In Create Free Account

About BBCZ Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.

Figures are derived from filed reports and may be restated. Historical data is subject to revision.